论文部分内容阅读
目的:观察康复新液联合奥美拉唑治疗慢性糜烂性胃炎的临床疗效分析。方法:选择2011年1月~2014年1月明确诊治的64例慢性糜烂性胃炎患者,随机分为观察组34例和对照组30例,观察组采用康复新液联合奥美拉唑治疗,对照组仅给予奥美拉唑治疗,对两组进行临床症状改善及胃镜下黏膜糜烂灶愈合质量的比较分析。结果:两组症状控制总有效率分别为94.1%和73.3%(χ~2=5.222,P<0.05),内镜下改善总有效率分别为91.2%和70%(χ~2=5.007,P<0.05)。两组均无严重不良反应。结论:康复新液联合奥美拉唑治疗慢性糜烂性胃炎的临床疗效显著,康复新液能减轻炎症反应,促进糜烂性胃黏膜的愈合,且安全、方便,值得临床应用推广。
Objective: To observe the curative effect of Kangfuxin solution combined with omeprazole in the treatment of chronic erosive gastritis. Methods: Sixty-four patients with chronic erosive gastritis diagnosed and treated from January 2011 to January 2014 were randomly divided into observation group (34 cases) and control group (30 cases). The observation group was treated with Kangfuxin Solution combined with omeprazole. The control group Group only given omeprazole treatment, the two groups to improve the clinical symptoms and endoscopic mucosal erosion lesion quality comparison analysis. Results: The total effective rates of the two groups were 94.1% and 73.3%, respectively (χ ~ 2 = 5.222, P <0.05). The total effective rates of endoscopic treatment were 91.2% and 70% (χ ~ 2 = 5.007, P <0.05). No serious adverse reactions in both groups. Conclusion: Kangfuxin solution combined with omeprazole in the treatment of chronic erosive gastritis has a significant therapeutic effect. Kangfuxin solution can reduce the inflammatory reaction and promote the healing of erosive gastric mucosa. It is safe and convenient and should be popularized clinically.